MR BIOINVEST ApS: Financial statements 2023
CVR: 25942817
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
MR BIOINVEST ApS (CVR 25942817) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -30,675 and a net result of DKK 1,861,816 compared with DKK -2,554,036 the year before. Equity in the 2023 report amounted to DKK 25,045,091. The solvency ratio was 99.6%.
- Gross Profit
- DKK -30,675
- Profit/Loss
- DKK 1,861,816
- Equity
- DKK 25,045,091
- Total Assets
- DKK 25,142,692
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -31K | 1.9M | 25M | 0 |
| 2022 | - | -28K | -2.6M | 23.2M | 0 |
| 2021 | - | -34K | 2.7M | 25.7M | 0 |
| 2020 | - | -83K | -102K | 23M | 0 |
| 2019 | - | -33K | 2.9M | 23.1M | 0 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
MR BIOINVEST ApS has published its annual report for 2022. Gross profit came to DKK -27,500, and the net result was DKK -2,554,036.
About MR BIOINVEST ApS
MR BIOINVEST ApS is a Danish company of the type Anpartsselskab based in Gentofte, founded in 2001. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Mads Aage Laustsen. The company is owned by Mads Aage Laustsen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -31,875 and a net result of DKK 1,503,262 compared with DKK 1,669,196 the year before. Equity in the 2025 report amounted to DKK 28,217,549.
